tiprankstipranks

Mark Van Oene Insider Profile

4 Followers
Mark Van Oene, SVP Chief Commercial Officer at Illumina, holds 1.63M shares in Pacific Biosciences (Ticker: PACB), holds 16.57K shares in Illumina (Ticker: ILMN). Most recently, Mark Van Oene Sold ― shares of Pacific Biosciences on Aug 20, 2024 for an estimated value of 63.10K.
tipranks
Mark Van Oene

Mark Van Oene
Illumina (ILMN)
SVP Chief Commercial Officer

Ranked #11,518 out of 99,335 Corporate Insiders

Profitable Transactions

80%
4 out of 5 Profitable Transactions

Average Return

+31.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
55.97%
44.03%
A breakdown of Mark Van Oene's holdings

Insider Roles

Pacific Biosciences
(PACB)
COO
Illumina
(ILMN)
SVP Chief Commercial Officer
Roles that Mark Van Oene holds in companies

Most Profitable Insider Trade

Stock:
Pacific Biosciences
(PACB)
Rating:Informative Sell
Date:Aug 18, 2023 - Aug 18, 2024
Return:+84.90%
The most profitable trade made by Mark Van Oene

Mark Van Oene's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Illumina
Nov 09, 2020
SVP Chief Commercial Officer
Uninformative Sell
334.48K
$2.27M
Pacific Biosciences
Aug 20, 2024
COO
Informative Sell
63.10K
$2.89M
List of latest transactions for each holding click on a transaction to see Mark Van Oene's performance on stock

Mark Van Oene insider profile FAQ

What is the percentage of profitable transactions made by Mark Van Oene?
The percentage of profitable transactions made by Mark Van Oene is 80%.
    What is the average return per transaction made by Mark Van Oene?
    The average return per transaction made by Mark Van Oene is 31.30%.
      What stocks does Mark Van Oene hold?
      Mark Van Oene holds: ILMN, PACB stocks.
        What was Mark Van Oene’s latest transaction?
        Mark Van Oene latest transaction was an Informative Sell of $63.10K.
          What was Mark Van Oene's most profitable transaction?
          Mark Van Oene’s most profitable transaction was an Informative Sell of PACB stock on August 18, 2023. The return on the trade was 84.90%.
            What is Mark Van Oene's role in Illumina?
            Mark Van Oene's role in Illumina is SVP Chief Commercial Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.